of the ethanol extract was carried out by adapting the method of Oyaizu [5] . Different concentrations of the extracts (1000, 500, 250, 125, 62.5, 31.25 µg/ml) were prepared. To all the test tubes 2.5 ml of sodium phosphate buffer followed by 2.5 ml of 1% potassium ferrocyanide solution was added. The contents were vortexed well and then incubated at 50° for 20 min. After incubation, 2.5 ml of 10 % trichloroacetic acid was added to all the tubes and centrifugation was carried out at 3000 rpm for 10 min. To 5 ml of the supernatant, 5 ml of distilled water was added. To this about 1 ml of 1% ferric chloride was added to each test tube and incubated at 35° for 10 min. The absorbance was read at 700 nm. The reducing power of the extract was linearly proportional to the concentration of the sample. Ascorbic acid was taken as reference standard. The result of phytochemical analysis was recorded in Table 1 . The leaf extract of P. edulis exhibited potential antioxidant activity in the both the assay models (Tables 2 and 3) Hydrochlorothiazide (HZ) [1] is a benzothiazidine derivative used as diuretic agent. Quinapril [1] (QP) is an isoquinoline carboxylic acid derivative used in treatment of hypertension. Literature survey [2] [3] [4] [5] [6] [7] [8] [9] [10] [11] revealed that only a few analytical methods including LC-MS, HPLC methods were reported for the determination of quinapril and its metabolite, in dosage form and plasma. HPLC and LC-MS methods have been reported for the estimation of hydrochlorothiazide alone and also in combination with other drugs. A derivative spectroscopy and chemometric methods have been reported for the simultaneous estimation of quinapril and hydrochlorothiazide. However, so far no HPLC method has been reported for simultaneous estimation of quinapril and hydrochlorothiazide in combination. Hence, this paper reports a simple, precise and accurate HPLC method for the simultaneous estimation of quinapril and hydrochlorothiazide from combined dosage form.
Separation was carried out on an isocratic HPLC system, Shimadzu LC-Class 10AT VP pump with PDA detector, Class LC 10 software and RP-C 18 Gemini (150×4.5 mm, 5 µ). The chromatographic estimation was performed using the following conditions: the mobile phase used was of 0.1% v/v triethylamine (pH 3.5), containing 1 mM of hexane sulphonic acid: acetonitrile (30:70 %v/v). The run time and flow rate were 6 min and 1 ml/min, respectively. Detection wavelength was set at 220 nm.
Standard stock solutions 1 mg/ml of QP and 1.2 mg/ml of HZ were prepared in acetonitrile. For construction of calibration graph, working standard solution were prepared by further diluting the stock solution with mobile phase to get a concentration of 30-150 µg/ml of QP and 40-200 µg/ml of HZ. This method was applied to determine QP and HZ in combined formulation of market samples. For the analysis of tablet formulation an accurately weighed tablet powder equivalent to 10 mg of QP and 12.5 mg of HZ were taken in a volumetric flask. The powder was dissolved in acetonitrile, shaken thoroughly and made upto the volume with acetonitrile, Then the solution was filtered through Whatman filter paper No. 41 and further diluted with mobile phase to get the concentration of 90 µg/ml and 120 µg/ml of QP and HZ, respectively. These solutions were injected and the chromatograms were recorded. A typical chromatogram of HZ and QP is shown in fig 1. The method was validated in terms of linearity, accuracy, inter-day and intra-day precision, reproducibility and specificity. The limit of detection and limit of quantification was also determined. The accuracy of the method was evaluated by carrying out recovery studies. For that, known concentrations of standard were added to the pre-analyzed sample solution and the recovery was calculated. The precision was determined by analyzing standard solutions in the linearity range of calibration curve in triplicate on the same day (intra day precision) and different days (inter day precision). The corresponding relative standard deviation were determined and found to be < 2.5. The validated data is furnished in Table 1 . The high percentage of recovery of the drugs indicates that the method is highly accurate and reliable ( Table 2 ). The content and the percentage of drugs in market samples (Table 3) indicate that the proposed method is simple, rapid, precise and accurate for the estimation of quinapril and hydrochlorothiazide in its pharmaceutical formulation.
